[CLDX] YoY Quarter Result on 31-Dec-2010 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
09-Mar-2011
Financial Year
2010
Quarter
31-Dec-2010 [#Q4]
Profit Trend
QoQ- 349.38%
YoY- 275.08%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 620 3,647 2,434 37,721 4,733 2,988 1,720 -15.62%
PBT -22,062 -16,807 -12,294 23,046 -13,020 -6,386 -5,254 26.98%
Tax -137 -94 268 1,449 -159 -1,444 -314 -12.89%
NP -22,062 -16,807 -12,732 22,661 -12,943 -7,453 -5,254 26.98%
Tax Rate - - - -6.29% - - - -
Total Cost 22,682 20,454 15,166 15,060 17,676 10,442 6,974 21.69%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin -3,558.39 -460.84 -523.09 60.08 -273.46 -249.41 -305.49 50.50%
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
EPS -3.71 -4.03 -3.81 10.61 -6.13 -7.08 -7.78 -11.60%
EPS Diluted -3.71 -4.03 -3.81 10.61 -6.13 -7.07 -7.78 -11.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.